AI Powers Advances in Preclinical Imaging Analysis
Preclinical imaging is already a powerful research and diagnostic tool. Now studies using CT, MRI, PET, and optical imaging technologies among others, are playing an important role in drug discovery and development. Preclinical imaging can save the pharmaceutical industry time and money by assessing the effects of drug candidates earlier in the drug pipeline— ultimately helping to get new drugs to patients faster. Applying artificial intelligence to image data analysis is advancing the field, allowing the development of innovative solutions where biology, physics, and computer science intersect.